EnChroma® Expands Indoor Lens Collection for Color Blindness and Adds Retail Partners

At Vision Expo East EnChroma, Inc. announced the expansion of its line of indoor lenses for color blindness with the addition of EnChroma® Clip-On...

Eye Exams And Alzheimer’s

Add another disease that it appears can be diagnosed early with a comprehensive eye exam, Alzheimer’s. Alzheimer's is a brain disease that causes a...

Contacts at Night Can Reduce Glasses by Day

UH Tackles Increased Childhood Myopia Nearsightedness, or myopia, the condition of those who can’t see objects at a distance, is increasing at an “alarming” rate,...

Ocutrx Vision Technologies Appoints Dr. Linda Lam as Chief Scientific and Strategy Officer

Ocutrx Vision Technologies, LLC, a California-based developer of augmented reality (AR) glasses, today announced that Dr. Linda Lam, MD, MBA, joined the company’s executive...

January is National Glaucoma Awareness Month

Today, nearly three million people ages 40 and older have glaucoma, according to the Prevent Blindness report, “Future of Vision: Forecasting the Prevalence and Costs of...

Eye Drops For Leukemia Treatment

Researchers at Wellcome Sanger Institute at the University of Cambridge, University of Nottingham and their collaborators have discovered that an active ingredient in eye...
Optical Business News - News - The Optical Vision Site

Ora To Provide Mobility Test Services

Ora® Inc. has been retained by ProQR Therapeutics to provide standardized mobility test services for ProQR's Phase 3 development program for Leber's Congenital Amaurosis Type 10....

NTU Scientists Develop Contact Lens Patch To Treat Eye Diseases

Nanyang Technological University, Singapore (NTU Singapore) scientists have developed a ‘contact lens’ patch with microneedles that could provide a painless and efficient alternative to...

EnChroma Launches New Color Blind Glasses Engineered for Strong Protans

EnChroma, Inc. – creators of glasses for color blindness – today announced the new EnChroma® Cx3 Sun SP™ lens, a new lens specially engineered...

Common Diabetes Drug Slows Age-Related Vision Loss In Tests

Metformin, a common type 2 diabetes drug marketed commonly as Glucophage, has shown promise as a treatment for age-related macular degeneration according to recent...

More Than a Third of Americans At High Risk for Diabetes-Related Vision Loss

More than 30 million Americans with diabetes and another 84 million who have prediabetes are at risk for developing diabetic eye disease, the leading cause of...

LumiThera and Optos Announce Collaboration For Treating Dry Age-Related Macular Degeneration

LumiThera Inc., a commercial-stage medical device company focused on developing photobiomodulation (PBM) therapies for ocular disorders and disease, announced a distribution agreement with Optos...

Oxurion NV Supporting Sight-Saving Programs For Those with Diabetes

To help support the fight against vision loss and blindness due to diabetes, Oxurion NV (formerly known as ThromboGenics), a biopharmaceutical company developing innovative...

20/20NOW Implements Retinal AI in All of Its Ocular Telehealth Exams

20/20NOW, the pioneer and innovator of Ocular Telehealth, recently announced their use of Artificial Intelligence ("AI") to allow for the early detection of retinal...

Essilor Launches Initiative to Help Combat Myopia In The U.S.

Myopia is one of the most prevalent vision issues globally, especially in children. By 2050, it is estimated nearly five billion people will be...

Must Read

FREE DELIVERY! 
Sign up to get  The Optical Vision Site delivered directly to your inbox!
Unsubscribe anytime. Your email address is never shared.

Enter your email address:

close-link